Pharmacogenetics as a Way for Personalizing Diuretic Therapy: Focus on Torasemide
Optimizing diuretic therapy in patients with chronic heart failure is a complicated problem with many unresolved questions. Diuretics take an important place in the treatment of heart failure, which are used in almost 80% of cases. Currently, there are not enough clinical studies, which comparative...
Saved in:
| Main Authors: | N. M. Gafurova, E. V. Shikh, O. D. Ostroumova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2021-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2396 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure
by: N. M. Gafurova, et al.
Published: (2020-09-01) -
CLINICAL EFFICACY OF LOOP DIURETIC TORASEMIDE IN TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. RESULTS OF KAZAKHSTAN MULTICENTER STUDY "POET"
by: S. F. Berkinbaev, et al.
Published: (2015-09-01) -
TOXICOLOGICAL AND PHARMACOLOGICAL CHARACTERISTICS OF EXCIPIENTS OF DRUG PRODUCTS OF TORASEMIDE
by: D. Yu. Ivkin, et al.
Published: (2019-01-01) -
CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01) -
EFFECT OF FUROSEMIDE AND TORASEMIDE ON HEART RATE VARIABILITY AND VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE COMPLICATING ISCHEMIC HEART DISEASE: COMPARATIVE NONRANDOMIZED STUDY
by: H. H. Shugushev, et al.
Published: (2016-01-01)